Concepedia

Maha Dalal

MD

Statistics

Publications

11

Citations

1.1K

H-Index

11

Active since

1985

Affiliations

National Cancer Institute(Current)

National Cancer Institute

St. Jude Children's Research Hospital

Maha Dalal is an author at National Cancer Institute specializing in pharmacology, antiviral pharmacology, and medicine.

Publications per year

1985–1987

11

Publications

11

Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity

David A. Cooney, Maha Dalal, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1986 · 322 citations

, , +10

The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.

Jan Balzarini, Gil-Jong Kang, Maha Dalal et al. · Molecular Pharmacology · 1987 · 234 citations

, , +14

Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity

Gurpreet S. Ahluwalia, David A. Cooney, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1987 · 147 citations

, , +11

Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidine

Jan Balzarini, Rudi Pauwels, Piet Herdewijn et al. · Biochemical and Biophysical Research Communications · 1986 · 130 citations

, , +13

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity

David A. Cooney, Gurpreet S. Ahluwalia, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1987 · 102 citations

, , +11

1–5 of 11